9th Annual Biomarkers Congress
Pharma MedComms World Europe 2011
4 -18 Harrington Gardens
4 -18 Harrington Gardens London SW7 4LH United Kingdom
London SW7 4LH , United Kingdom
http://www.healthnetworkcommunications.com/2011/pharma-medcomms-world-europe/index.stm
    *  Build communication programmes for local decision-makers after health reforms  
    * Create a drug value proposition which shows cost-effectiveness to healthcare payers 
    * Develop a tactical publication strategy for a new product
    * Provide physicians and patients up-to-date information and support using the latest technologies 
    * Work alongside patient advocacy groups to make an effective educational programme
    * Engage healthcare professionals ethically through continuing medical education (CME) and as key opinion leaders (KOL)
    * Utilise the latest social media, online resources and apps to convey your messages on disease awareness and the latest therapeutics
This is the single most important event to network with the senior players within medical communications and learn about the latest innovations in the sector.


http://www.healthnetworkcommunications.com/2011/pharma-medcomms-world-europe/index.stm

Schedule of Presentations:

Tuesday, September 27, 2011
06:00:00 MORNING SESSION- Medical writing for publications Andrea Palluch, Adam Jacobs, Alison McIntosh
09:25:00 Pre Conference Workshop | Effective medical writing from clinical trial investigations Alison McIntosh
13:00:00 AFTERNOON SESSION- Medical writing for regulatory submissions Andrea Palluch, Adam Jacobs, Alison McIntosh
Wednesday, September 28, 2011
08:00:00 Registration & refreshments
08:35:00 CHALLENGES IN MEDICAL COMMUNICATIONS TODAY
08:40:00 Opening remarks from chair
08:50:00 Key challenges in medical communications today
09:10:00 How to communicate transparently with physicians and other health care providers via the peer-reviewed scientific literature
09:30:00 Zen and the art of crisis management - planning, prevention, preparing and performing
09:50:00 How the EMA is regulating the provision of information in medicines Juan García Burgos
10:10:00 How the US FDA communicates the risks of pharmaceutical products Julie Zawisza
10:30:00 Speed networking and morning refreshments
11:10:00 THE NEW PAYER
11:15:00 The new NHS and the challenges this presents industry – who will the payer be? Sam Taylor
11:35:00 Panel session- Strategies for communicating to the new payers after healthcare reform Ross Carroll, Georgina Craig
11:55:00 WORKING WITH PATIENTS
12:05:00 Providing patients with the right information in the right way
12:25:00 Lunch
13:25:00 Providing the right information to patients across global regions
13:45:00 Employing user-testing to improve the readability and usability of medicines information Theo Raynor
14:15:00 Addressing challenges for making patient summaries and ePrescription interoperable
14:45:00 Afternoon refreshments
15:15:00 The role of nurses in effective patient communication
15:45:00 Improving healthcare delivery for chronic diseases through better communication Soren E. Skovlund
16:15:00 Developing resources to support country-level affiliates in patient advocacy interactions
16:45:00 Panel session- Is there a patient in the house? - Working alongside patient advocacy groups Keith Allan, Deborah Rodbard, Emma Pennery
17:15:00 Closing remarks from the chair
17:25:00 Drinks reception
19:30:00 Gala Dinner
Thursday, September 29, 2011
08:00:00 Registration & refreshments
08:25:00 Opening remarks from the chair
08:30:00 Keynote- Improving patient outcomes in the new NHS structure Jim Easton
08:55:00 Ensuring patient engage in their own healthcare
09:20:00 Working alongside patient advocacy groups – A US perspective
09:45:00 What can pharma do in terms of patient communication? Alexandra Wyke
10:10:00 Integrating product and disease communications
10:30:00 Morning refreshments
10:55:00 WORKING WITH HEALTHCARE PROFESSIONALS
11:00:00 Consultant-industry communication to improve patient outcomes
11:20:00 Insights from medical information on the dialogue with physicians
11:35:00 WORKING WITH KEY OPINION LEADERS (KOLs)
11:40:00 Developing strategic partnerships with KOLs to improve creditability & reach
12:00:00 Panel Session- The value of KOLs in communication strategies
12:30:00 Lunch
13:25:00 SUPPORTING CONTINUING MEDICAL EDUCATION (CME)
13:30:00 Using medical education to improve treatment outcomes
13:50:00 Harmonization of CME in Europe, a Challenge for UEMS-EACCME
14:15:00 The variety of CME accreditation systems in Europe Madeleine Schaffer
14:40:00 How online CME can change professional behaviour & improve patient care? John Sandars
15:00:00 Afternoon refreshments
15:30:00 Panel session- CME to improve treatment outcomes Madeleine Schaffer
15:55:00 PUBLICATION PLANNING
16:00:00 Establishment of medical publication best practices
16:20:00 Optimizing your publication strategy: strategic imperatives> scientific platforms> tactics> implementation
16:40:00 Identifying the best means of communicating data
17:00:00 The evolution of open access in clinical publications Keith Veitch
17:20:00 Accessible medical research Trish Groves
17:40:00 Panel Session- Medical publication standards and best practices Michaela Torkar, Emma Veitch
18:10:00 Closing remarks from the chair
18:20:00 End of conference
Friday, September 30, 2011
09:25:00 Post Conference Workshop | Key opinion leader development
09:30:00 MORNING SESSION
13:00:00 AFTERNOON SESSION
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.